Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in four disease areas: bone and mineral; intractable hematologic; hematology oncology; and rare disease. A Japan-based company,
The Chief Financial Officer for this Critical Access Hospital (CAH) will be an employee of Community Hospital Corporation (CHC), working under the joint direction of the local Hospital CEO and CHC’s SVP of Hospital Financial Operations.